714 related articles for article (PubMed ID: 25892679)
21. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial.
Albers GW; von Kummer R; Truelsen T; Jensen JK; Ravn GM; Grønning BA; Chabriat H; Chang KC; Davalos AE; Ford GA; Grotta J; Kaste M; Schwamm LH; Shuaib A;
Lancet Neurol; 2015 Jun; 14(6):575-84. PubMed ID: 25937443
[TBL] [Abstract][Full Text] [Related]
22. The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.
Westendorp WF; Vermeij JD; Zock E; Hooijenga IJ; Kruyt ND; Bosboom HJ; Kwa VI; Weisfelt M; Remmers MJ; ten Houten R; Schreuder AH; Vermeer SE; van Dijk EJ; Dippel DW; Dijkgraaf MG; Spanjaard L; Vermeulen M; van der Poll T; Prins JM; Vermeij FH; Roos YB; Kleyweg RP; Kerkhoff H; Brouwer MC; Zwinderman AH; van de Beek D; Nederkoorn PJ;
Lancet; 2015 Apr; 385(9977):1519-26. PubMed ID: 25612858
[TBL] [Abstract][Full Text] [Related]
23. Very early mobilisation and complications in the first 3 months after stroke: further results from phase II of A Very Early Rehabilitation Trial (AVERT).
Sorbello D; Dewey HM; Churilov L; Thrift AG; Collier JM; Donnan G; Bernhardt J
Cerebrovasc Dis; 2009; 28(4):378-83. PubMed ID: 19641313
[TBL] [Abstract][Full Text] [Related]
24. Pharyngeal electrical stimulation for early decannulation in tracheotomised patients with neurogenic dysphagia after stroke (PHAST-TRAC): a prospective, single-blinded, randomised trial.
Dziewas R; Stellato R; van der Tweel I; Walther E; Werner CJ; Braun T; Citerio G; Jandl M; Friedrichs M; Nötzel K; Vosko MR; Mistry S; Hamdy S; McGowan S; Warnecke T; Zwittag P; Bath PM;
Lancet Neurol; 2018 Oct; 17(10):849-859. PubMed ID: 30170898
[TBL] [Abstract][Full Text] [Related]
25. Early Mobilization After Stroke Is Not Associated With Cognitive Outcome.
Cumming TB; Bernhardt J; Lowe D; Collier J; Dewey H; Langhorne P; Thrift AG; Green A; Mohanraj R; Kramer SF; Churilov L; Linden T;
Stroke; 2018 Sep; 49(9):2147-2154. PubMed ID: 30354969
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial.
AFFINITY Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):651-660. PubMed ID: 32702334
[TBL] [Abstract][Full Text] [Related]
27. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial.
Middleton S; McElduff P; Ward J; Grimshaw JM; Dale S; D'Este C; Drury P; Griffiths R; Cheung NW; Quinn C; Evans M; Cadilhac D; Levi C;
Lancet; 2011 Nov; 378(9804):1699-706. PubMed ID: 21996470
[TBL] [Abstract][Full Text] [Related]
28. Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Bernhardt J; Churilov L; Ellery F; Collier J; Chamberlain J; Langhorne P; Lindley RI; Moodie M; Dewey H; Thrift AG; Donnan G;
Neurology; 2016 Jun; 86(23):2138-45. PubMed ID: 26888985
[TBL] [Abstract][Full Text] [Related]
29. The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Ma L; Hu X; Song L; Chen X; Ouyang M; Billot L; Li Q; Malavera A; Li X; Muñoz-Venturelli P; de Silva A; Thang NH; Wahab KW; Pandian JD; Wasay M; Pontes-Neto OM; Abanto C; Arauz A; Shi H; Tang G; Zhu S; She X; Liu L; Sakamoto Y; You S; Han Q; Crutzen B; Cheung E; Li Y; Wang X; Chen C; Liu F; Zhao Y; Li H; Liu Y; Jiang Y; Chen L; Wu B; Liu M; Xu J; You C; Anderson CS;
Lancet; 2023 Jul; 402(10395):27-40. PubMed ID: 37245517
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of fluoxetine on functional recovery after acute stroke (EFFECTS): a randomised, double-blind, placebo-controlled trial.
EFFECTS Trial Collaboration
Lancet Neurol; 2020 Aug; 19(8):661-669. PubMed ID: 32702335
[TBL] [Abstract][Full Text] [Related]
31. Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands.
Huijberts I; Pinckaers FME; Olthuis SGH; van Kuijk SMJ; Postma AA; Boogaarts HD; Roos YBWEM; Majoie CBLM; van der Lugt A; Dippel DWJ; van Zwam WH; van Oostenbrugge RJ;
Lancet Neurol; 2024 Jun; ():. PubMed ID: 38909624
[TBL] [Abstract][Full Text] [Related]
32. Robot assisted training for the upper limb after stroke (RATULS): a multicentre randomised controlled trial.
Rodgers H; Bosomworth H; Krebs HI; van Wijck F; Howel D; Wilson N; Aird L; Alvarado N; Andole S; Cohen DL; Dawson J; Fernandez-Garcia C; Finch T; Ford GA; Francis R; Hogg S; Hughes N; Price CI; Ternent L; Turner DL; Vale L; Wilkes S; Shaw L
Lancet; 2019 Jul; 394(10192):51-62. PubMed ID: 31128926
[TBL] [Abstract][Full Text] [Related]
33. Very early rehabilitation or intensive telemetry after stroke: a pilot randomised trial.
Langhorne P; Stott D; Knight A; Bernhardt J; Barer D; Watkins C
Cerebrovasc Dis; 2010; 29(4):352-60. PubMed ID: 20130401
[TBL] [Abstract][Full Text] [Related]
34. Home-based constraint-induced movement therapy for patients with upper limb dysfunction after stroke (HOMECIMT): a cluster-randomised, controlled trial.
Barzel A; Ketels G; Stark A; Tetzlaff B; Daubmann A; Wegscheider K; van den Bussche H; Scherer M
Lancet Neurol; 2015 Sep; 14(9):893-902. PubMed ID: 26231624
[TBL] [Abstract][Full Text] [Related]
35. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.
Robinson TG; Potter JF; Ford GA; Bulpitt CJ; Chernova J; Jagger C; James MA; Knight J; Markus HS; Mistri AK; Poulter NR;
Lancet Neurol; 2010 Aug; 9(8):767-75. PubMed ID: 20621562
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial.
Alexandrov AV; Köhrmann M; Soinne L; Tsivgoulis G; Barreto AD; Demchuk AM; Sharma VK; Mikulik R; Muir KW; Brandt G; Alleman J; Grotta JC; Levi CR; Molina CA; Saqqur M; Mavridis D; Psaltopoulou T; Vosko M; Fiebach JB; Mandava P; Kent TA; Alexandrov AW; Schellinger PD;
Lancet Neurol; 2019 Apr; 18(4):338-347. PubMed ID: 30878103
[TBL] [Abstract][Full Text] [Related]
37. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.
Baharoglu MI; Cordonnier C; Al-Shahi Salman R; de Gans K; Koopman MM; Brand A; Majoie CB; Beenen LF; Marquering HA; Vermeulen M; Nederkoorn PJ; de Haan RJ; Roos YB;
Lancet; 2016 Jun; 387(10038):2605-2613. PubMed ID: 27178479
[TBL] [Abstract][Full Text] [Related]
38. Effect of very early mobilisation on functional status in patients with acute stroke: a single-blind, randomized controlled trail.
Chippala P; Sharma R
Clin Rehabil; 2016 Jul; 30(7):669-75. PubMed ID: 26198890
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of three enteral feeding strategies in patients with severe stroke in China (OPENS): a multicentre, prospective, randomised, open-label, blinded-endpoint trial.
Zhao J; Yuan F; Song C; Yin R; Chang M; Zhang W; Zhang B; Yu L; Jia Y; Ma Y; Song Y; Wang C; Song C; Wang X; Shang L; Yang F; Jiang W;
Lancet Neurol; 2022 Apr; 21(4):319-328. PubMed ID: 35219379
[TBL] [Abstract][Full Text] [Related]
40. Effect of baseline Alberta Stroke Program Early CT Score on safety and efficacy of intra-arterial treatment: a subgroup analysis of a randomised phase 3 trial (MR CLEAN).
Yoo AJ; Berkhemer OA; Fransen PSS; van den Berg LA; Beumer D; Lingsma HF; Schonewille WJ; Sprengers MES; van den Berg R; van Walderveen MAA; Beenen LFM; Wermer MJH; Nijeholt GJLÀ; Boiten J; Jenniskens SFM; Bot JCJ; Boers AMM; Marquering HA; Roos YBWEM; van Oostenbrugge RJ; Dippel DWJ; van der Lugt A; van Zwam WH; Majoie CBLM;
Lancet Neurol; 2016 Jun; 15(7):685-694. PubMed ID: 27302238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
